ALS Valuation
| ALQ Stock | 15.95 0.11 0.69% |
At this time, the firm appears to be fairly valued. ALS shows a prevailing Real Value of USD15.35 per share. The current price of the firm is USD15.95. Our model approximates the value of ALS from reviewing the firm fundamentals such as profit margin of 0.01 %, and Return On Equity of 0.0117 as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that ALS's price fluctuation is not too volatile at this time. Calculation of the real value of ALS is based on 3 months time horizon. Increasing ALS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
ALS's intrinsic value may or may not be the same as its current market price of 15.95, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.95 | Real 15.35 | Hype 15.95 | Naive 16.43 |
The intrinsic value of ALS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ALS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ALS helps investors to forecast how ALS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ALS more accurately as focusing exclusively on ALS's fundamentals will not take into account other important factors: ALS Total Value Analysis
ALS is presently projected to have takeover price of 9.6 B with market capitalization of 7.15 B, debt of 1.87 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ALS fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.6 B | 7.15 B | 1.87 B |
ALS Investor Information
About 41.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.12. ALS last dividend was issued on the 12th of June 2024. The entity had 5:1 split on the 2nd of August 2012. Based on the key indicators related to ALS's liquidity, profitability, solvency, and operating efficiency, ALS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.ALS Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ALS has an asset utilization ratio of 66.6 percent. This implies that the Company is making USD0.67 for each dollar of assets. An increasing asset utilization means that ALS is more efficient with each dollar of assets it utilizes for everyday operations.ALS Ownership Allocation
ALS holds a total of 484.57 Million outstanding shares. 30% of ALS outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Thus, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.ALS Profitability Analysis
The company reported the revenue of 2.46 B. Net Income was 12.9 M with profit before overhead, payroll, taxes, and interest of 752.8 M.About ALS Valuation
The stock valuation mechanism determines ALS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of ALS based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of ALS. We calculate exposure to ALS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ALS's related companies.Additional Tools for ALS Stock Analysis
When running ALS's price analysis, check to measure ALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALS is operating at the current time. Most of ALS's value examination focuses on studying past and present price action to predict the probability of ALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALS's price. Additionally, you may evaluate how the addition of ALS to your portfolios can decrease your overall portfolio volatility.